CURATIVE BIOSCIENCES INC

As of March 31, 2018, CURATIVE BIOSCIENCES INC carries a market capitalization of 4.31M, placing it among publicly traded companies globally. Its enterprise value stands at 4.64M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2018, CURATIVE BIOSCIENCES INC has 19.57M shares outstanding.

These figures are as of March 31, 2018.

As of March 31, 2018, CURATIVE BIOSCIENCES INC maintains a current ratio of 0.00, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2018. Return on assets (ROA) is negative at -6,150.23, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 220.00, a quick read on workforce productivity versus industry peers.

As of the close on July 29, 2026, CURATIVE BIOSCIENCES INC's stock has gained approximately 0.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.06.

Over the twelve months ended March 31, 2018, CURATIVE BIOSCIENCES INC generated - - in revenue and converted that into -518,095.00 in net income, yielding earnings per share of -0.03. EBITDA reached -515,487.00, while operating income came in at -518,095.00.

As of March 31, 2018, CURATIVE BIOSCIENCES INC holds 982.00 in cash and equivalents against 338,421.00 in total debt, resulting in a net debt position of 155,471.00. Total book value stands at -705,669.00, with working capital of -718,558.00 providing operational flexibility.

CURATIVE BIOSCIENCES INC produced -81,808.00 in operating cash flow over the twelve months ended March 31, 2018.

These figures cover the twelve months ended March 31, 2018. Free cash flow yield is negative at -2.22: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -2.21, meaning CURATIVE BIOSCIENCES INC raised more capital through share issuance and new debt than it returned via dividends and buybacks.

CURATIVE BIOSCIENCES INC's most recent stock split took place on November 1, 2013 with a 100:1 split ratio.

As of March 31, 2018, CURATIVE BIOSCIENCES INC has an Altman Z-Score of -57,509.08, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.